60 Degrees Pharmaceuticals Boosted by Promising Study Results

60 Degrees Pharmaceuticals shares are trading higher after announcing positive results from a study linking Babesia infection to chronic fatigue, validating the continuation of their B-FREE study to evaluate ARAKODA for treatment of chronic babesiosis.